Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to… Read More »Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health
NEXE Innovations Inc. (NEXE.V) announced today that retail distribution is planned for three of its XOMA Superfoods beverages at 78 London Drug locations in Canada.… Read More »NEXE Innovations (NEXE.V) Expands Offering Outside of eCommerce, Enters Retail Market with XOMA Superfoods
The US Dollar (DXY) has confirmed a major breakout on the weekly chart. A breakout which means that the US Dollar bull run will continue.… Read More »The One Chart That Has Stock Markets on Edge
In recent weeks we’ve seen M&A activity in the gold sector begin to pick up. In September Agnico Eagle and Kirkland Lake announced their intention… Read More »Arizona Metals (AMC.V): Fundamental Rich—now Cash Rich
Arizona Metals (AMC.V) is a mining company that owns two properties in, you guessed it, Arizona. The two properties are the 100% Kay Mine which… Read More »Chart Attack: Arizona Metals (AMC.V) Ready to Test Record Highs as Gold Heads to $1900!
TORONTO, On October 20, 2021, Arizona Metals Corp. (“AMC.V”) announced that it had entered into an amended agreement with Stifel GMP and Clarus Securities Inc… Read More »Analysis: Arizona Metals Corp (AMC.V) Announces Upsize to Previously Announced Bought Deal Financing
Plurilock Security Inc (“PLUR.V”) Plurilock is an identity-centric cybersecurity solutions provider to businesses.The Cyber Security Market Size, Share & Trends Analysis Report By Grand View… Read More »Analysis: Plurilock Security (PLUR.V) June sales $8.6 million from $80,000 in March period
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and… Read More »Arizona Metals (AMC.V) – Investor Roundtable #3
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the… Read More »Canntab Therapeutics (PILL.C) hits major milestone, gets medical sales license
